Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/24328
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-02-02T07:16:38Z | - |
dc.date.available | 2022-02-02T07:16:38Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Baran, İ. vd. (2005). "Prognostic value of viable myocardium in patients with non-Q-wave and Q-wave myocardial infarction". Journal of International Medical Research, 33(5), 574-582. | en_US |
dc.identifier.issn | 0300-0605 | - |
dc.identifier.issn | 1473-2300 | - |
dc.identifier.uri | https://doi.org/10.1177/147323000503300513 | - |
dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/147323000503300513 | - |
dc.identifier.uri | http://hdl.handle.net/11452/24328 | - |
dc.description.abstract | This study assessed the amount and prognostic value of myocardial viability in patients with non-Q-wave myocardial infarction (NQMI) and Q-wave myocardial infarction (QMI). A total of 175 patients with MI and an ejection fraction <= 45% underwent dobutamine stress echocardiography. On the basis of clinical criteria and myocardial viability, 110 patients were revascularized. The amount of viable myocardium and the clinical outcome were compared in the NQMI and QMI groups. Patients with NQMI exhibited a larger amount of viable myocardium compared with those with QMI. The mortality rate was 6% in patients with NQMI with viable myocardium and subsequent revascularization, 33% in patients with NQMI without viable myocardium or revascularization, 27% in patients with QMI with viable myocardium and subsequent revascularization, and 33% in patients with QMI without viable myocardium or revascularization. In conclusion, our data suggest that patients with NQMI and viable myocardium have the best prognosis after revascularization. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Research & experimental medicine | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Viable myocardium | en_US |
dc.subject | Non-Q-wave myocardial infarction | en_US |
dc.subject | Q-wave myocardial infarction | en_US |
dc.subject | Revascularization | en_US |
dc.subject | Survival | en_US |
dc.subject | Left-ventricular dysfunction | en_US |
dc.subject | Coronary-artery-disease | en_US |
dc.subject | Positron-emission-tomography | en_US |
dc.subject | Dobutamine echocardiography | en_US |
dc.subject | Contractile reserve | en_US |
dc.subject | Tl-201 tomography | en_US |
dc.subject | Viability | en_US |
dc.subject | Hibernation | en_US |
dc.subject | Prediction | en_US |
dc.title | Prognostic value of viable myocardium in patients with non-Q-wave and Q-wave myocardial infarction | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000232068600013 | tr_TR |
dc.identifier.scopus | 2-s2.0-25844498738 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-7528-3557 | tr_TR |
dc.contributor.orcid | 0000-0002-8974-8837 | tr_TR |
dc.identifier.startpage | 574 | tr_TR |
dc.identifier.endpage | 582 | tr_TR |
dc.identifier.volume | 33 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | Journal of International Medical Research | en_US |
dc.contributor.buuauthor | Baran, İbrahim | - |
dc.contributor.buuauthor | Özdemir, B. Handan | - |
dc.contributor.buuauthor | Güllülü, Sümeyye | - |
dc.contributor.buuauthor | Kaderli, Aysel Aydın | - |
dc.contributor.buuauthor | Şentürk, Tunay | - |
dc.contributor.buuauthor | Aydınlar, Ali | - |
dc.contributor.researcherid | C-1517-2017 | tr_TR |
dc.contributor.researcherid | X-8540-2019 | tr_TR |
dc.contributor.researcherid | AAI-6632-2021 | tr_TR |
dc.identifier.pubmed | 16222891 | tr_TR |
dc.subject.wos | Medicine, research & experimental | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 35572557400 | tr_TR |
dc.contributor.scopusid | 7004168959 | tr_TR |
dc.contributor.scopusid | 57204660708 | tr_TR |
dc.contributor.scopusid | 7801322152 | tr_TR |
dc.contributor.scopusid | 8342098300 | tr_TR |
dc.contributor.scopusid | 6603131517 | tr_TR |
dc.subject.scopus | ST Segment Elevation Myocardial Infarction; Stroke Volume; Coronary Angiography | en_US |
dc.subject.emtree | Dobutamine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cell viability | en_US |
dc.subject.emtree | Coronary artery bypass graft | en_US |
dc.subject.emtree | Coronary stent | en_US |
dc.subject.emtree | Electrocardiogram | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Heart ejection fraction | en_US |
dc.subject.emtree | Heart infarction | en_US |
dc.subject.emtree | Heart muscle | en_US |
dc.subject.emtree | Heart muscle revascularization | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Non q wave myocardial infarction | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Q wave | en_US |
dc.subject.emtree | Q wave myocardial infarction | en_US |
dc.subject.emtree | Stress echocardiography | en_US |
dc.subject.emtree | Survival time | en_US |
dc.subject.emtree | Transluminal coronary angioplasty | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Baran_vd_2005.pdf | 79.01 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License